F.A.Q.
Sign in
0 Product Products (empty)

No products

€0.00 Total

Check out

Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products
Continue shopping Proceed to checkout
Sciva International s.r.o.
Menu
  • Home
  • E-SHOP
    • CBD oils
    • Capsules
      • Veterinary products
      • Wellness products
      • Cosmetic products
    • About us
    • RESEARCH DATA
      • ANXIETY
      • ALZHEIMER´S
      • ADDICTION
      • ADD/ADHD
      • AIDS
      • ALS
      • ANOREXIA
      • ANTIBIOTIC RESISTANCE
      • ARTHRITIS
      • ATHEROSCLEROSIS
      • ASTHMA
      • AUTISM
      • BIPOLAR
      • CANCER STUDIES
      • CHRONS AND STOMACH PROBLEMS
      • DEPRESSION
      • DIABETES
      • ENDOCRINE DISORDERS
      • EPILEPSY/SEIZURE
      • FIBRYOMALGI
      • GLAUCOMA
      • HEART DISEASE
      • HUNTINGTON´S
      • INFLAMATIONS
      • IRRITABLE BOWEL SYNDROM
      • KIDNEY DISEASE
      • LIVER DISEASE
      • METABOLIC SYNDROME
      • MIGRAINE
      • MOOD DISORDERS
      • MOTION SICKNESS
      • MS/MULTIPLE SCLEROSIS
      • NAUSEA
      • NEURODEGENERATION
      • NEUROPATHIC PAIN
      • OBESITY
      • OCD
      • OSTEOPOROSIS
      • PARKINSON DISEASE
      • PRION/MAD COW DISEASE
      • PTSD
      • RHEUMATISM
      • SCHIZOPHRENIA
      • SICKLE CELL ANEMIA
      • SKIN CODITION
      • SLEEP DISORDERS
      • SPINAL CORD INJURY
      • STRESS
      • STROKE/TBI
    • Blog
    • Testimonials
    • Contact
    / RESEARCH DATA/ SKIN CODITION

    Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis (PubMed)

    Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (PubMed)

    The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities (PubMed)

    Epigenetic control of skin differentiation genes by phytocannabinoids (PubMed)

    A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ (PubMed)

    Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1 (PubMed)

    Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation (PubMed)

    Attenuation of allergic contact dermatitis through the endocannabinoid system (PubMed)

    Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus (PubMed)


    Stay connected

    • Facebook
    • Youtube
    • Instagram

    Our website processes cookies in order to increase the user-friendliness of the website and, in the case of your consent, to personalize ads. More info

    close

    Disclaimer

    This website is an initiative of the company Sciva International s.r.o., which has its head office in Prague, the Czech Republic.

    Sciva International s.r.o. shall not be held liable for the medical claims made by customers. It should be noted that these products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care professionals. Sciva International s.r.o. does not make any health claims about our products except those officially approved by EFSA and recommends consulting with health care professionals prior to consuming our products. It is especially important for those who are pregnant, nursing, chronically ill, elderly to discuss the use of these products with health care professionals. You must be 18 years or older to visit this website and/or purchase the products. The website may contain references in the form of hyperlinks, banners or buttons for example, to third party websites. Sciva International s.r.o. has no authority over these websites. The rights relating to this website, including those of intellectual ownership, copyright on text, streaming videos, images, design, data files, photographs and other (moving or stationary) visual material, audio material, formats, software, brands (including domain names) and other material are held by Sciva International s.r.o. and/or its licensing body.

    © 2023 Sciva Corporation s.r.o. All Rights Reserved.



    Cookies Consent to processing of personal data

    © 2023 Sciva Corporation s.r.o. All Rights Reserved.

    Are you more than
    18 years of age?

    Yes No